These findings led to the development of an effective patient-centered intervention program to improve awareness and lifestyle practices, in which unique challenges reported by participants with known higher risk of diabetes-related blindness (on insulin treatment and/or longer duration of diabetes) were addressed [28]. The gene discussed is INS; the disease is blindness (disorder).